Maximum quantity allowed is 999
请选择数量
CAS RN: 69975-86-6 | 產品號碼: D4302
產品號碼 | D4302 |
純度/分析方法 | >98.0%(T)(HPLC) |
分子式 / 分子量 | C__1__1H__1__4N__4O__4 = 266.26 |
外觀與形狀(20°C) | Solid |
儲存條件 | Room Temperature (Recommended in a cool and dark place, <15°C) |
包裝和容器 | 1G-Glass Bottle with Plastic Insert (閲覽圖片) |
CAS RN | 69975-86-6 |
Reaxys-RN | 561195 |
PubChem Substance ID | 253659730 |
Merck Index(14) | 3438 |
MDL編號 | MFCD00865218 |
產品規格
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
Melting point | 142.0 to 146.0 °C |
性質
熔點 | 144 °C |
GHS
圖形表示 |
![]() |
信號詞 | Warning |
危險性說明 | H302 : Harmful if swallowed. |
防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
相關法規
RTECS # | XH5135000 |
運輸資料
HS編碼* | 2934.99-000 |
Application
Studies of the Mechanism of Action of Doxofylline
References
- Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects
- The mechanism of action of doxofylline is unrelated to HDAC inhibition, PDE inhibition or adenosine receptor antagonism
Application
Analyses of Doxofylline in Serum
References
- Non-extraction HPLC method for simultaneous measurement of dyphylline and doxofylline in serum
- F. Tagliaro, R. Dorizzi, A. Frigerio, M. Marigo, Clin. Chem. 1990, 36, 113.
- Development and validation of a stability-indicating RP-HPLC method for analysis of doxofylline in human serum. Application of the method to a pharmacokinetic study
- R. Gannu, S. Bandari, S. G. Sudke, Y. M. Rao, B. P. Shankar, Acta Chromatogr. 2007, 19, 149.
考研文獻
文檔
產品介紹報導
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。